ArticleAlimentary pharmacology & therapeutics2018

Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease.

N Vande Casteele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.